Chris Aiken, MD (@chrisaikenmd) 's Twitter Profile
Chris Aiken, MD

@chrisaikenmd

Editor, Carlat Psychiatry Report.
Assist Prof, NYU & WFU medical schools.
Never received pharma funding.
Posting daily research to learn, discuss, debate.

ID: 1536098282929258500

linkhttps://chrisaikenmd.com/ calendar_today12-06-2022 21:29:27

3,3K Tweet

7,7K Takipçi

931 Takip Edilen

Chris Aiken, MD (@chrisaikenmd) 's Twitter Profile Photo
Chris Aiken, MD
@chrisaikenmd

7 months ago

FDA approved suzetrigine (Journavx): first pain med that works by blocking peripheral Na channels and doesn't enter the brain > Non-addictive > Equaled Vicodin in large trials of post-surgical pain > Possible benefits in diabetic neuropathy fda.gov/news-events/pr…

FDA approved suzetrigine (Journavx): first pain med that works by blocking peripheral Na channels and doesn't enter the brain > Non-addictive > Equaled Vicodin in large trials of post-surgical pain > Possible benefits in diabetic neuropathy fda.gov/news-events/pr…